CIBC World Market
OVID icon

CIBC World Market’s Ovid Therapeutics OVID Stock Holding History

CIBC World Market’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$554K Buy
+249,351
New +$446K ﹤0.01% 1091

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CIBC World Market's OVID Position: Q1 2026 in Review

CIBC World Market opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 249,351 shares worth $554K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings.

103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • CIBC World Market held 249,351 shares of Ovid Therapeutics worth $554K as of Q1 2026.
  • Ovid Therapeutics was a new CIBC World Market position in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #1091 holding.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.